-
1
-
-
34250350040
-
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
-
DOI 10.1097/HJH.0b013e3281fc975a, PII 0000487220070600000001
-
Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187 (Pubitemid 46924065)
-
(2007)
Journal of Hypertension
, vol.25
, Issue.6
, pp. 1105-1187
-
-
Mancia, G.1
De Backer, G.2
Dominiczak, A.3
Cifkova, R.4
Fagard, R.5
Germano, G.6
Grassi, G.7
Heagerty, A.M.8
Kjeldsen, S.E.9
Laurent, S.10
Narkiewicz, K.11
Ruilope, L.12
Rynkiewicz, A.13
Schmieder, R.E.14
Boudier, H.A.J.S.15
Zanchetti, A.16
-
2
-
-
0347423198
-
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
-
DOI 10.1161/01.HYP.0000107251.49515.c2
-
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252 (Pubitemid 37553153)
-
(2003)
Hypertension
, vol.42
, Issue.6
, pp. 1206-1252
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo Jr., J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright Jr., J.T.10
Roccella, E.J.11
-
3
-
-
0025805484
-
Effects of amlodipine on urinary sodium excretion, renin-angiotensin- aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension
-
Cappuccio FP, Markandu ND, Sagnella GA, et al. Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. J Hum Hypertens 1991;5:115-119
-
(1991)
J Hum Hypertens
, vol.5
, pp. 115-119
-
-
Cappuccio, F.P.1
Markandu, N.D.2
Sagnella, G.A.3
-
4
-
-
4143107839
-
Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor
-
DOI 10.1152/ajplung.00312.2003
-
Olson S, Oeckler R, Li X, et al. Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor. Am J Physiol Lung Cell Mol Physiol 2004;287:559-568 (Pubitemid 39095912)
-
(2004)
American Journal of Physiology - Lung Cellular and Molecular Physiology
, vol.287
, Issue.3
-
-
Olson, S.1
Oeckler, R.2
Li, X.3
Du, L.4
Traganos, F.5
Zhao, X.6
Burke-Wolin, T.7
-
5
-
-
20844448074
-
Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients
-
Karas M, Lacourciere Y, LeBlanc AR, et al. Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients. J Hypertens 2005;23:1251-1260 (Pubitemid 40862730)
-
(2005)
Journal of Hypertension
, vol.23
, Issue.6
, pp. 1251-1260
-
-
Karas, M.1
Lacourciere, Y.2
Leblanc, A.-R.3
Nadeau, R.4
Dube, B.5
Florescu, M.6
Lamarre-Cliche, M.7
Poirier, L.8
Larochelle, P.9
De Champlain, J.10
-
6
-
-
52049097072
-
Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes
-
Imanishi T, Tsujioka H, Ikejima H, et al. Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Hypertension 2008;52:563-572
-
(2008)
Hypertension
, vol.52
, pp. 563-572
-
-
Imanishi, T.1
Tsujioka, H.2
Ikejima, H.3
-
7
-
-
28744436699
-
Antioxidant and nitric oxide-sparing actions of dihydropyridines and ACE inhibitors differ in human endothelial cells
-
DOI 10.1159/000088854
-
Lob H, Rosenkranz AC, Breitenbach T, et al. Antioxidant and nitric oxide-sparing actions of dihydropyridines and ACE inhibitors differ in human endothelial cells. Pharmacology 2006;76:8-18 (Pubitemid 41759057)
-
(2006)
Pharmacology
, vol.76
, Issue.1
, pp. 8-18
-
-
Lob, H.1
Rosenkranz, A.C.2
Breitenbach, T.3
Berkels, R.4
Drummond, G.5
Roesen, R.6
-
8
-
-
0036016107
-
Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- And kinin-dependent mechanism
-
Xu B, Xiao-Hong L, Lin G, et al. Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism. Br J Pharmacol 2002;136:375-382 (Pubitemid 34620518)
-
(2002)
British Journal of Pharmacology
, vol.136
, Issue.3
, pp. 375-382
-
-
Xu, B.1
Xiao-hong, L.2
Lin, G.3
Queen, L.4
Ferro, A.5
-
9
-
-
34547925543
-
Aliskiren: A review of its use in the management of hypertension
-
DOI 10.2165/00003495-200767120-00008
-
Frampton JE, Curran MP. Aliskiren: a review of its use in the management of hypertension. Drugs 2007;67:1767-1792 (Pubitemid 47263181)
-
(2007)
Drugs
, vol.67
, Issue.12
, pp. 1767-1792
-
-
Frampton, J.E.1
Curran, M.P.2
-
10
-
-
53349092083
-
Direct renin inhibition: An evaluation of the safety and tolerability of aliskiren
-
Rashid H. Direct renin inhibition: an evaluation of the safety and tolerability of aliskiren. Curr Med Res Opin 2008;24:2627-2637
-
(2008)
Curr Med Res Opin
, vol.24
, pp. 2627-2637
-
-
Rashid, H.1
-
11
-
-
36248931230
-
Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy
-
Drummond W, Munger MA, Essop MR, et al. Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy. J Clin Hypertens 2007;9:742-750
-
(2007)
J Clin Hypertens
, vol.9
, pp. 742-750
-
-
Drummond, W.1
Munger, M.A.2
Essop, M.R.3
-
12
-
-
0033953234
-
Amlodipine, enalapril, and dependent leg edema in essential hypertension
-
Pedrinelli R, Dell'Omo G, Melillo E, et al. Amlodipine, enalapril, and dependent leg edema in essential hypertension. Hypertension 2000;35:621-625 (Pubitemid 30108158)
-
(2000)
Hypertension
, vol.35
, Issue.2
, pp. 621-625
-
-
Pedrinelli, R.1
Dell'Omo, G.2
Melillo, E.3
Mariani, M.4
-
13
-
-
0642274210
-
Incidence of pedal edema formation with dihydropyridine calcium channel blockers: Issues and practical significance
-
Greenwich
-
Weir MR. Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance. J Clin Hypertens (Greenwich) 2003;5:330-335
-
(2003)
J Clin Hypertens
, vol.5
, pp. 330-335
-
-
Weir, M.R.1
-
14
-
-
67649345134
-
E1: The extent of population exposure to assess clinical safety for drugs intended for long-term treatment of non-life-threatening conditions
-
International Conference on Harmonization
-
International Conference on Harmonization. E1: The extent of population exposure to assess clinical safety for drugs intended for long-term treatment of non-life-threatening conditions. In: International Conference on Harmonization, 1994
-
International Conference on Harmonization, 1994
-
-
-
15
-
-
67649331137
-
Long-term safety and efficacy of combination therapy with amlodipine and valsartan in hypertensive patients
-
Abstract P-70
-
Smith TR, Glazer R, Koren MJ, et al. Long-term safety and efficacy of combination therapy with amlodipine and valsartan in hypertensive patients. J Clin Hypertens 2008;10:A35 (Abstract P-70)
-
(2008)
J Clin Hypertens
, vol.10
-
-
Smith, T.R.1
Glazer, R.2
Koren, M.J.3
-
16
-
-
43549100189
-
The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study
-
DOI 10.1016/j.clinthera.2008.04.002, PII S0149291808001410
-
Chrysant SG, Melino M, Karki S, et al. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clin Ther 2008;30:587-604 (Pubitemid 351680489)
-
(2008)
Clinical Therapeutics
, vol.30
, Issue.4
, pp. 587-604
-
-
Chrysant, S.G.1
Melino, M.2
Karki, S.3
Lee, J.4
Heyrman, R.5
-
17
-
-
60549087324
-
Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: A 12-month randomized, double-blind comparator trial with hydrochlorothiazide
-
Schmieder RE, Philipp T, Guerediaga J, et al. Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide. Circulation 2009;119:417-425
-
(2009)
Circulation
, vol.119
, pp. 417-425
-
-
Schmieder, R.E.1
Philipp, T.2
Guerediaga, J.3
-
18
-
-
2642547176
-
Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension
-
DOI 10.1016/j.amjhyper.2004.02.003, PII S0895706104000408
-
Jamerson KA, Nwose O, Jean-Louis L, et al. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Am J Hypertens 2004;17:495-501 (Pubitemid 38726163)
-
(2004)
American Journal of Hypertension
, vol.17
, Issue.6
, pp. 495-501
-
-
Jamerson, K.A.1
Nwose, O.2
Jean-Louis, L.3
Schofield, L.4
Purkayastha, D.5
Baron, M.6
-
19
-
-
67649326611
-
Effect of telmisartan addition to amlodipine on reduction of incidence of peripheral oedema: Safety analysis from a factorial study in hypertension
-
Abstract P-51
-
Littlejohn T, Majul C, Oigman W, et al. Effect of telmisartan addition to amlodipine on reduction of incidence of peripheral oedema: safety analysis from a factorial study in hypertension. J Clin Hypertens 2008;10:A27 (Abstract P-51)
-
(2008)
J Clin Hypertens
, vol.10
-
-
Littlejohn, T.1
Majul, C.2
Oigman, W.3
-
20
-
-
39049139033
-
Blood pressure control in patients initiating antihypertensive therapy
-
DOI 10.1345/aph.1K506
-
Weycker D, Edelsberg J, Vincze G, et al. Blood pressure control in patients initiating antihypertensive therapy. Ann Pharmacother 2008;42:169-176 (Pubitemid 351238563)
-
(2008)
Annals of Pharmacotherapy
, vol.42
, Issue.2
, pp. 169-176
-
-
Weycker, D.1
Edelsberg, J.2
Vincze, G.3
Levy, D.G.4
Kartashov, A.5
Oster, G.6
|